Profile
RNTX ONC INSM WBA HROWL HROWM
Company Name Rein Therapeutics Inc. BeOne Medicines Ltd. Insmed Incorporated Walgreens Boots Alliance, Inc. Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 11.875% Senior Notes due 2027
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals
Market Cap $26.98M $36.88B $30.44B $10.37B $1.37B $1.34B
Employees 0.01K 11.00K 1.27K 193.00K 0.22K 0.22K
CEO James Brian Windsor John V. Oyler William H. Lewis Timothy C. Wentworth Mark L. Baum Mark L. Baum
Trading
RNTX ONC INSM WBA HROWL HROWM
Last Close $1.16 $345.17 $152.8 $11.98 $25.6 $26.02
High 52 $2.7 $351.13 $152.84 $12.93 $25.72 $27.25
Low 52 $1.08 $175.1 $64.81 $8.24 $25.01 $25.85
Price vs. 52 Week High -57.04 % -1.7 % -0.03 % -7.35 % -0.47 % -4.51 %
Price vs. 52 Week Low 7.41 % 97.13 % 135.77 % 45.39 % 2.36 % 0.66 %
Total Return
RNTX ONC INSM WBA HROWL HROWM
1 Month Return -8.66 % 2.64 % 6.48 % 0 % 1.48 % -0.61 %
3 Month Return -23.18 % 40.6 % 56.24 % 4.45 % 0.39 % -2.18 %
6 Month Return -30.12 % 30.59 % 108.36 % 8.32 % 0.83 % -2 %
9 Month Return 0 % 90.62 % 118.94 % 26.11 % 0.79 % -1.89 %
YTD Return 0 % 87.59 % 121.32 % 28.4 % 1.28 % -0.72 %
1 Year Return 0 % 0 % 114.01 % 38.18 % -0.04 % -3.52 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
RNTX ONC INSM WBA HROWL HROWM
Dividend Yield Percentage (TTM) - - - 2.09 % - -
Dividend Paid and Capex Coverage Ration (TTM) - 1.36 % -35.17 % 0.96 % 0.11 % 0.11 %
Dividend Per Share (TTM) - - - 0.25 % - -
Payout Ratio (TTM) - -7.46 % - -10.29 % - -
Growth
RNTX ONC INSM WBA HROWL HROWM
Asset Growth -41.33 % 1.99 % -16.14 % 24.6 %
Gross Profit Growth - 54.71 % -2.02 % 66.06 %
Revenue Growth - 54.96 % 6.17 % 53.32 %
Revenue 3 Year - 185.46 % 11.65 % 106.71 %
Revenue 5 Year - 407.52 % 31.29 % 177.12 %
Revenue 10 Year - 14520 % 113.45 % 2980.52 %
EBIT Growth -183063.93 % 52.95 % -183.88 % 281.28 %
Net Income Growth -399613.96 % 26.87 % -180.39 % 28.39 %
Net Income 3 Yeari Growth Per Share -59389.19 % 59.8 % -440.4 % 27.14 %
Net Income 5 Yeari Growth Per Share - 61.31 % -331.55 % -7490.95 %
Net Income 10 Yeari Growth Per Share - -1664.38 % -593.61 % 55.74 %
Operating Income Growth -399949.15 % 52.95 % -104.53 % 1946.87 %
Operating Cash Flow Growth (CFG) -12.54 % 87.85 % -54.92 % -678.18 %
Operating 3 Year CFG 76.77 % 90.46 % -81.64 % -427.89 %
Operating 5 Year CFG - 89.31 % -80.57 % -1760.01 %
Operating 10 Year CFG - -709.03 % -71.12 % 19.39 %
EPS Growth -2.63 % 27.57 % -180.39 % 34.67 %
EPS Diluted Growth -2.63 % 27.57 % -180.39 % 34.67 %
Book Value Per Share 102.44 % -6.6 % -57.24 % -9.96 %
Share Holder 3 Year Equity Growth Per Share -69.34 % -52.96 % -56.07 % 363.19 %
Share Holder 5 Year Equity Growth Per Share - 94.27 % -53.83 % 78.54 %
Share Holder 10 Year Equity Growth Per Share - 6367.84 % -43.9 % 118.93 %
Dividend Per Share Growth - - -24.04 % -
Dividend 3 Year Growth Per Share - - -21.92 % -100 %
Dividend 5 Year Growth Per Share - - -18.12 % -
Dividend 10 Year Growth Per Share - - 16.05 % -
Debt Growth -100 % 16.09 % -2.03 % 20.12 %
Free Cash Flow Growth -12.54 % 61.81 % -357.45 % 59.06 %
Updated On 31 Dec 2024 31 Dec 2024 31 Aug 2024 31 Dec 2024
Profitability
RNTX ONC INSM WBA HROWL HROWM
Gross Profit Margin TTM - 85.48 % 75.4 % 17.13 % 74.56 % 74.56 %
Return on Assets TTM -92.75 % -3.14 % -41.71 % -9.07 % -2.96 % -2.96 %
Return on Equity TTM -189.54 % -5.64 % -195.37 % -70.17 % -17.5 % -17.5 %
Return on Capital Employed TTM -123.23 % -2.93 % -43.62 % -7.17 % 14.97 % 14.97 %
Net Income Per EBT TTM 88 % 241.23 % 100.43 % 109.84 % 95.39 % 95.39 %
EBT Per Ebit TTM 98.75 % 68.65 % 108.89 % 184.02 % -74.47 % -74.47 %
EBIT Per Revenue TTM - -2.56 % -237.59 % -2.02 % 6.32 % 6.32 %
Cash Flow To Debt Ratio TTM - 55.69 % -146.75 % 5.43 % 1.75 % 1.75 %
Receivables Turnover TTM - 5.3 7.23 23.42 2.88 2.88
Payables Turnover TTM - 1.88 1.32 9.41 2.47 2.47
Inventory Turnover TTM - 1.35 0.91 17.5 5.01 5.01
Fixed Asset Turnover TTM - 264.26 % 339.6 % 556.84 % 1951.32 % 1951.32 %
Asset Turnover TTM - 74.11 % 16.05 % 222.72 % 65.98 % 65.98 %
Operating Cash Flow Per Share TTM -0.88 5.35 -4.46 1.82 0.11 0.11
Free Cash Flow Per Share TTM -0.88 1.54 -4.59 0.67 -0.93 -0.93
Cash Per Share TTM 23.66 % 2579.15 % 980.85 % 95.96 % 143.96 % 143.96 %
Operating Cash Flow Sales Ratio TTM - 12.24 % -212.14 % 1.02 % 1.77 % 1.77 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 28.86 % 102.84 % 36.78 % -851.67 % -851.67 %
Cash Flow Coverage Ratios TTM - 55.69 % -146.75 % 5.43 % 1.75 % 1.75 %
Price To Free Cash Flows Ratio TTM -1.27 240.05 -35.05 17.88 -51.37 -51.37
Price To Operating Cash Flows Ratio TTM -1.32 8.06 -32.28 6.57 434.98 434.98
Price Cash Flow Ratio TTM -1.32 8.06 -32.28 6.57 434.98 434.98
Income Statement (TTM)
RNTX ONC INSM WBA HROWL HROWM
Revenue $0B $3.81B $0.36B $147.66B $0.2B $0.2B
Gross Profit $-0B $3.22B $0.28B $26.52B $0.15B $0.15B
Gross Profit Ratio 0% 84.41% 76.43% 17.96% 75.33% 75.33%
EBITDA $-0.03B $-0.4B $-0.81B $-11.28B $0.02B $0.02B
Net Income $-0.06B $-0.64B $-0.91B $-8.64B $-0.02B $-0.02B
EPS Diluted -3.51 -6.12 -5.57 -10.01 -0.49 -0.49
Balance Sheet (MRQ)
RNTX ONC INSM WBA HROWL HROWM
Long Term Debt $0B $0.21B $1.14B $29.88B $0.23B $0.23B
Total Liabilities $0.01B $2.59B $1.74B $68.86B $0.32B $0.32B
Total Equity $0.05B $3.33B $0.29B $12.18B $0.07B $0.07B
Total Investments $0B $0.13B $0.88B $4.06B $0B $0B
Total Debt $0B $1.08B $1.15B $32.85B $0.23B $0.23B
Total Assets $0.06B $5.92B $2.03B $81.04B $0.39B $0.39B
Cash Flow Statement (TTM)
RNTX ONC INSM WBA HROWL HROWM
Net Income $-0.06B $-0.64B $-0.91B $-15.45B $-0.02B $-0.02B
Inventory $0B $-0.09B $-0.02B $-0.03B $165B $165B
Dividends Paid $0B $0B $0B $-1.26B $0B $0B
Operating Cash Flow $-0.02B $-0.14B $-0.68B $1.02B $-0.02B $-0.02B
Capital Expenditure $0B $-0.53B $-0.02B $-1.38B $-0.04B $-0.04B
Related Stocks
Ticker Name Price
ATNFW CannBioRx Life Sciences Corp. 0.43
BGMS Bio Green Med Solution, Inc. 4.68
BGMSP Bio Green Med Solution, Inc. 5.75
BIMI BIMI International Medical Inc. 0.0001
CGEM Cullinan Oncology, Inc. 5.89
CJJD China Jo-Jo Drugstores, Inc. 1.52
HITI High Tide Inc. 3.57
HROWL Harrow Health, Inc. 8.625% Senior Notes due 2026 25.63
HROWM Harrow Health, Inc. 11.875% Senior Notes due 2027 26.04
INSM Insmed Incorporated 157.23
LFLY Leafly Holdings, Inc. 37
LFLYW Leafly Holdings, Inc. 0.004
LFMD LifeMD, Inc. 6.97
LFMDP LifeMD, Inc. 23.8
MDVL MedAvail Holdings, Inc. 1.8
MEDS TRxADE HEALTH, Inc. 7.59
NEUP 19.46
ONC 343.75
PETS PetMed Express, Inc. 2.62
RAD Rite Aid Corporation 0.6483
ETFs With Exposure to RNTX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00003 329.96
VXF Vanguard Extended Market Index Fund 0.00047 212.07
ONEQ Fidelity Nasdaq Composite Index ETF 0 89.68
IWC iShares Micro-Cap ETF 0.0055 152.06
VTSAX Vanguard Total Stock Market Index Fund 0.00003 160.52
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00047 160.39
VITSX Vanguard Total Stock Market Index Fund 0.00003 160.54
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00047 160.4
VTS.AX Vanguard US Total Market Shares Index ETF 0.00003 501.78
VEMPX Vanguard Extended Market Index InstlPlus 0.00047 395.8
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00003 301.15
Unlock